Literature DB >> 2567760

Nosocomial Branhamella catarrhalis in a paediatric intensive care unit: risk factors for disease.

P P Cook1, D W Hecht, D R Snydman.   

Abstract

There have been few reports on Branhamella catarrhalis as a nosocomial pathogen, and no risk factors for nosocomial infection have been identified. We report 11 cases (mean age 22 months) of nosocomial Branhamella catarrhalis respiratory tract infection in a paediatric intensive care unit (PICU) over a two-year period. There were 2 cases of pneumonia and 9 cases of bronchitis. Branhamella catarrhalis was the sole isolate recovered in 6 cases and was associated with other respiratory pathogens in 5 cases. A case-control study with two age-matched controls per patient (mean age 24.1 months) was undertaken to identify potential risk factors for infection; risk factors identified were the presence of an endotracheal tube (p less than 0.02) and frequent endotracheal tube suction (p less than 0.05). Five of 6 tested strains from PICU patients produced beta-lactamase. DNA preparations of 4 B. catarrhalis isolates from PICU patients revealed no plasmids. B. catarrhalis should be considered a potential nosocomial pathogen.

Entities:  

Mesh:

Year:  1989        PMID: 2567760     DOI: 10.1016/0195-6701(89)90011-x

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  9 in total

1.  Identification and characterization of a novel outer membrane protein (OMP J) of Moraxella catarrhalis that exists in two major forms.

Authors:  John P Hays; Saskia van Selm; Theo Hoogenboezem; Silvia Estevão; Kimberly Eadie; Peter van Veelen; Jan Tommassen; Alex van Belkum; Peter W M Hermans
Journal:  J Bacteriol       Date:  2005-12       Impact factor: 3.490

2.  Pulmonary thin-section CT findings in acute Moraxella catarrhalis pulmonary infection.

Authors:  F Okada; Y Ando; T Nakayama; S Tanoue; R Ishii; A Ono; M Watanabe; H Takaki; T Maeda; H Mori
Journal:  Br J Radiol       Date:  2010-12-01       Impact factor: 3.039

Review 3.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

4.  Molecular epidemiological characterization of respiratory isolates of Moraxella catarrhalis in a pediatric intensive care unit.

Authors:  A G Matlow; D E Low; G Paret; S Jarrett; D Bohn; G Barker; J Boulanger; E L Ford-Jones
Journal:  Can J Infect Dis       Date:  1992-07

Review 5.  Branhamella catarrhalis: epidemiology, surface antigenic structure, and immune response.

Authors:  T F Murphy
Journal:  Microbiol Rev       Date:  1996-06

Review 6.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

7.  Epidemiological typing of Moraxella catarrhalis by using DNA probes.

Authors:  D Beaulieu; S Scriver; M G Bergeron; D E Low; T R Parr; J E Patterson; A Matlow; P H Roy
Journal:  J Clin Microbiol       Date:  1993-03       Impact factor: 5.948

8.  Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection.

Authors:  M G Morgan; H McKenzie; M C Enright; M Bain; F X Emmanuel
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-04       Impact factor: 3.267

9.  Clinical characteristics of the patients with bacteremia due to Moraxella catarrhalis in children: a case-control study.

Authors:  Takanori Funaki; Eisuke Inoue; Isao Miyairi
Journal:  BMC Infect Dis       Date:  2016-02-09       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.